PubMed Health⌕ Search

PubMed · 8309717

[Are antibiotics immunomodulators?].

Abstract

This review of the literature, although non complete, involving different observations, experiments and documented demonstrations, suggest the real importance of the interrelations existing between, the pathogenic bacteria, the specific and non specific reactions of the normal or infected host and the antibiotics. The bacterial infections are potent immunomodulators by causing significant alterations in one or more mediators of homeostasis (coagulation, complement, inflammation), inducing cellular and tissular alterations more or less dramatic depending upon the number, the virulence of the bacteria and the immune status of the host. Antibiotics in reducing the number of the infecting pathologic bacteria, in modifying their pathologic and virulence factors might them be considered as immunorestoring molecules. On the other hand, when large numbers of bacteria are killed rapidly by bactericidal antibiotics, their cytoplasmic enzymes or bacterial cell wall structures, are rapidly released locally and are able to amplify the various systems involved in the deleterious inflammatory reaction. Thus depending on their dose and their mode of action, antibiotics could be considered as immunomodulators, albeit indirectly in modifying the pathophysiology of the host, in inhibiting or enhancing the release of immunoreactive bacterial molecules. Moreover antibiotics have been shown to interfere directly on the non specific and specific defenses mechanisms. Until the recent years, only the immunotoxicological aspect has been evaluated, involving mostly the immunopharmacologic screening of the antibiotics effects on phagocytic cells or on the effectors of the immune responses. Several recent examples are given that illustrate a new approach looking at the molecular level of the cellular action of antibiotics.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P H Lagrange. 1993. [Are antibiotics immunomodulators?].. https://pubmed.ncbi.nlm.nih.gov/8309717/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response.

Single-stranded RNA oligonucleotides containing an immunostimulatory motif (immunostimulatory RNA [isRNA]) are potent inducers of interferon-alpha via the Toll-like receptor 7. We investigated the effect of isRNA on the development of an immune response. We show that isRNA activates dendritic cells and induces production of Th1-type cytokines both in vitro and in vivo. Cytokine production led to bystander activation of T and B cells. We further demonstrate that isRNA triggers the generation of antigen-specific cytotoxic T cells and of an IgG2a-biased antibody response to antigen in a sequence-dependent manner. In summary, we provide evidence for the first time that isRNA oligonucleotides can simultaneously activate the innate and adaptive arms of the immune system.

Adjuvants, Immunologic↗

Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccination.

Dendritic-tumor heterokaryons generated by electrofusion are highly immunogenic. In animal studies, a single vaccination was therapeutic for tumors established in the lung, skin, and brain. However, effective therapy required a third signal which could be provided by exogenous IL-12 or the agonistic anti-OX-40R monoclonal antibody (mAb). In this study, we investigated the mechanism and mode of actions of these two seemingly distinct adjuvants. In immunotherapy of the MCA205 sarcoma, administration of the neutralizing anti-IL-12 mAb nearly completely blocked the adjuvant effect of IL-12, but had minimal inhibitory effects on anti-OX-40R mAb. By contrast, in vivo administration of the antagonistic anti-OX-40L mAb inhibited the adjuvant effects of both IL-12 and anti-OX-40R mAb. Thus, a common pathway of endogenous OX-40 interaction is critical for the development of a therapeutic immune response. Analysis of the third signal mechanism revealed that in the absence of an adjuvant, vaccination with fusion hybrids led to IL-10 production without eliciting IFN-gamma secreting cells. The addition of IL-12 to vaccination suppressed IL-10 production and initiated sensitization of specific IFN-gamma secreting cells, resulting in a type 1-like antitumor immunity. These findings underscore the significance of the third signal in the design of dendritic cell-based cancer vaccines.

Adjuvants, Immunologic↗